AKR1D1 and type 2 diabetes mellitus: The effects of dexamethasone on AKR1D1 gene expression are mirrored by genetic knockdown of AKR1D1. These findings suggest that downregulation of AKR1D1 would increase hepatic glucose output and exacerbate type 2 diabetes [33].